Cerevance

Cerevance

Cerevance

Cerevance is develops therapeutics for neurological and psychiatric disorders.
Suggest edits
Type
B2c
Founded
2016
Raised
$81M
Companies in the same industry
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2021
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 2

Add info
Latest funding
$45,000,000
Venture capital (Series B) - 2020
Foresite Capital GV Lightstone Ventures +3
$36,000,000
Venture capital (Series A) - 2016
Takeda Pharmaceutical Lightstone Ventures
Team Size
1–10
Employees
I work here
Location
United States
Headquarters
Explore United States
$45,000,000 Venture capital (Series B)
Xconomy

Cerevance Raises $45M to Advance Brain Disease Research & Development

Cerevance
Cerevance
$36,000,000 Venture capital (Series A)
takeda

CEREVANCE LAUNCHED WITH NEW TECHNOLOGY, DRUG PORTFOLIO AND $36M IN CASH TO TACKLE BRAIN DISEASES Pharmaceutical Company...